Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,545.5
-13.6 (-0.53%)

 

  • STI Straits Times Index
    2,545.5
    -13.6 (-0.53%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,578.1
    -10.4 (-0.66%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    24,531.6
    -399.0 (-1.60%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,354.0
    -32.4 (-0.96%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    22,329.9
    -88.2 (-0.39%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    5,143.9
    -34.4 (-0.66%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,268.2M
  • Value: 1,358.8M
  • Rise: 113
  • Fall: 217
  • Unch: 478

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Oceanus^0.008+0.001
ThaiBev0.605-0.020
Genting Sing0.680-0.030
Asian Healthcare0.285+0.050
Vicplas Intl0.390+0.065
ISDN0.395+0.030
AsiaMedic0.023+0.002
CNMC Goldmine0.360+0.015
Rex Intl0.184-0.003
Medtecs Intl0.970-0.030

World Indices

World Indices
Name Last Change
Nasdaq 9,757.2 -259.8
HSI 24,253.8 -296.2
HSCEI 9,745.8 -107.4
Jakarta 4,863.1 -41.0
Nikkei 225 22,064.8 -447.3
SSE Comp 2,959.0 -11.7
Shanghai A 3,101.5 -12.2
Shanghai B 211.6 -1.8
KOSPI 2,100.4 -34.3

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

BBI LIFE SCI BBI LIFE SCI
Quotes 15 Minutes Delayed. No Trades for The Day
Last (HKD): 3.490 Change: - High: 3.490 Remarks: D
Remarks legend:
Change (%): - Low: 3.490
Open 3.490 Yesterday's Close 3.490
Buy Price - Sell Price -
Buy Volume ('000) - Sell Volume ('000) -
Cumulative Volume ('000) - Cumulative Value -
Click to show Stock Prices chart

Key Statistics

EPS (HKD) a 0.17821 Trailing EPS (HKD) e 0.17821 NAV (HKD) b 1.7116
PE a 19.584 Trailing PE f 19.584 Price / NAV b 2.0390
Dividend (HKD) d 3.435597 Cash In Hand (HKD) g 0.1185 Issued & Paid-up Shares c -
Dividend Yield (%) d 98.441 Price / Cash In Hand g 29.451 Treasury Shares h -
Beta - 75 Daysi 0.070 R-Squared - 75 Days(%)i 1.37 Market Cap (M) -
Beta - 500 Daysi 0.375 R-Squared - 500 Days (%)i 3.83 Enterprise Value (M) -75.823
Piotroski F Score 6 Exchange Code 1035 Par Value ( HKD ) 0.01000
52 Weeks Volatility (%) 37.42 6-Month VWAP 3.294 Free Float (%) -
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 09 Jul 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 29 Jul 2015.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference BBI LIFE SCI HKEx - 19.584 19.584 2.0390 98.441
Industry Biotechnology HKEx 59,210.674 23.191 27.058 7.6263 2.161
Local Peer AMGEN-T HKEx 585,694.000 9.532 10.295 7.0897 4.589
Local Peer SINO BIOPHARM HKEx 183,064.220 59.645 60.190 5.2838 0.548
Local Peer WUXI BIO HKEx 228,464.733 198.740 198.739 15.9759 -
Local Peer BEIGENE HKEx 156,345.400 - - - -
Local Peer GENSCRIPT BIO HKEx 31,551.186 - - 10.5778 -
Local Peer 3SBIO HKEx 23,375.225 21.171 21.171 2.1711 -
Local Peer ALPHAMAB-B HKEx 15,682.212 - - 5.7792 -
Local Peer VIVA BIOTECH HKEx 19,664.148 65.227 65.226 9.8905 0.159
Local Peer HAOHAI BIOTEC HKEx 21,606.322 51.391 51.391 3.6734 0.631
Local Peer FRONTAGE HKEx 7,970.458 55.188 55.190 3.8659 -
Local Peer ASCENTAGE-B HKEx 8,317.959 - - 8.3508 -
Local Peer KINTOR PHARMA-B HKEx 5,851.138 - - 15.8289 -
Other Local Peers SINOMAB BIO-B (HKEx), ESSEX BIO-TECH (HKEx), ASCLETIS-B (HKEx), LEE'S PHARM (HKEx), UNI-BIO GROUP (HKEx), CT ENTERPRISE (HKEx), BIOSINO BIO-TEC (HKEx), REGENT PACIFIC (HKEx), HAO WEN HLDGS (HKEx)
Global Peer AMGEN INC NASDAQ 140,970.689 17.976 19.314 13.2255 2.433
Global Peer GILEAD SCIENCES INC NASDAQ 86,945.482 16.143 - 4.8231 3.669
Global Peer CSL ASX 124,495.695 46.403 42.977 14.3952 0.967
Global Peer VERTEX PHARMACEUTICAL NASDAQ 71,104.886 60.422 34.172 9.4564 -
Global Peer REGENERON PHARMACEUTICALS INC NASDAQ 65,985.364 31.187 22.117 7.2852 -
Global Peer ILLUMINA INC NASDAQ 52,282.020 52.178 80.932 - -
Global Peer BIOGEN INC NASDAQ 48,397.867 8.219 8.166 4.2797 -
Global Peer AGILENT TECHNOLOGIES INC NYSE 30,192.215 28.191 44.205 6.3322 0.672
Global Peer SEATTLE GENETICS INC NASDAQ 27,917.819 - - 15.3896 -
Global Peer ALEXION PHARMACEUTICAL INC NASDAQ 22,636.187 9.415 26.754 2.1577 -
Other Global Peers MODERNA INC (NASDAQ), INCYTE CORPORATION (NASDAQ), BIOMARIN PHARMACEUTICAL (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), EXACT SCIENCES CORP (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), BIONTECH SE SPON ADS EACH REP 1 ORD SHS (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), BIO-TECHNE CORP (NASDAQ), 10X GENOMICS INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), IMMUNOMEDICS INC (NASDAQ), EXELIXIS INC (NASDAQ), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), ACCELERON PHARMA (NASDAQ), BLUEBIRD BIO INC (NASDAQ), EMERGENT BIOSOLUTIONS INC (NYSE), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), Lonza (SGX), MIRATI THERAPEUTICS INC (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), MOMENTA PHARMACEUTICALS INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), FIBROGEN INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), ALKERMES PLC (NASDAQ), VIELA BIO INC (NASDAQ), NOVAVAX INC (NASDAQ), INSMED INC (NASDAQ), UNIQURE N.V. (NASDAQ), ALECTOR INC (NASDAQ), BENITEC BIOPHARMA INC (NASDAQ), TG THERAPEUTICS INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), EIDOS THERAPEUTICS INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), EPIZYME INC (NASDAQ), XENCOR INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC ADS EACH REPR 6 SHS (SPONS) (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), ARCUS BIOSCIENCES INC (NYSE), TWIST BIOSCIENCE CORPORATION (NASDAQ), ZENTALIS PHARMACEUTICALS INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), MESOBLAST LTD (ASX), DICERNA PHARMACEUTICALS INC. (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), EDITAS MEDICINE INC (NASDAQ), MYOVANT SCIENCES LTD (NYSE), INTRA-CELLUAR THERAPIES INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), ARVINAS INC (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), REGENXBIO INC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), BEAM THERAPEUTICS INC (NASDAQ), VERACYTE INC (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), BLACK DIAMOND THERAPEUTICS INC (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), CORTEXYME INC (NASDAQ), CYTOKINETICS INC (NASDAQ), POLYNOVO LIMITED (ASX), AIMMUNE THERAPEUTICS INC (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), COMPUGEN (NASDAQ), PASSAGE BIO INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), MACROGENICS INC (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), TRANSLATE BIO INC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), AVROBIO INC (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), OMEROS CORP (NASDAQ), IMMUNOGEN INC (NASDAQ), PLIANT THERAPEUTICS INC (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), AVITA MEDICAL LTD SPON ADS EACH REP 20 ORD SHS (NASDAQ), AVITA MEDICAL LTD (ASX), CARA THERAPEUTICS INC (NASDAQ), KADMON HLDGS INC (NYSE), HOMOLOGY MEDICINES INC (NASDAQ),